|

Creation of a Multicenter National Registry for Peripartum Cardiomyopathy.

RECRUITINGSponsored by Federico II University
Actively Recruiting
SponsorFederico II University
Started2024-02-21
Est. completion2025-02-19
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted

Summary

Peripartum cardiomyopathy (PPCM) is a rare, severe and potentially life-threatening disorder of largely unknown etiology and pathophysiology, with unexplained geographical differences and heterogeneous presentation. Investigators hypothesize that a network-based multidisciplinary strategy integrating clinical and molecular phenotyping of PPCM patients might anticipate diagnosis, optimize treatments, and identify novel mechanisms to achieve the unmet goal of personalized medicine.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria

* Development of HF signs or symptoms in the last month of pregnancy or within 5 months of delivery;
* Left ventricle systolic dysfunction demonstrated by classical echocardiographic criteria (LVEF\< 45 %) in the last month of pregnancy or within 5 months of delivery.

Exclusion Criteria

* Presence of any identifiable cause of HF;
* Presence of recognizable heart disease before the last month of pregnancy.

Conditions2

Heart DiseasePeripartum Cardiomyopathy

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.